Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question

Citation
Pm. Krein et al., Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question, EXPERT OP T, 11(7), 2001, pp. 1065-1079
Citations number
143
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EXPERT OPINION ON THERAPEUTIC PATENTS
ISSN journal
13543776 → ACNP
Volume
11
Issue
7
Year of publication
2001
Pages
1065 - 1079
Database
ISI
SICI code
1354-3776(200107)11:7<1065:GFRAMI>2.0.ZU;2-Q
Abstract
The process of tissue repair following injury is in the large part mediated by secreted growth factors which, in an autocrine or paracrine fashion, st imulate immune and mesenchymal cells at the site of injury. The complex pro cess of replacing damaged tissue with newly formed tissue involves componen ts of the blood, coagulation, immune and mesenchymal systems as well as cyt okines, chemokines, metalloproteinases and growth factors. This review will focus on growth factors as the controllers of this process and includes me mbers of the transforming growth factor (TGF), platelet derived growth fact or (PDGF), fibroblast growth factor (FGF), connective tissue derived growth factor (CTCF) and insulin-like growth factor-I (IGF-I) families of growth factors. These growth factors stimulate re-epithelialisation, angiogenesis, extracellular matrix (ECM) formation and cell proliferation each of which plays a role in tissue replacement and restoration of tissue function follo wing injury. Normal wound healing frequently involves the formation of scar tissue, including increased mesenchymal cell proliferation and excessive p roduction of ECM proteins. While scar tissue rapidly and effectively closes wounds, it leaves visually apparent tissue structure changes and may reduc e the function of the tissue leading to compromised organ function. Growth factors, the conductors of these processes, are targets for therapeutic man ipulation of wound healing and scar formation. Recent patents involving gro wth factors may be implicated in the treatment of wound healing following t issue injury. Enhanced growth factor activity may be beneficial to increase the rate of wound healing in chronic non-healing wounds, whereas reduction of growth factor presence or activity may reduce scar formation in the ski n and internal organs, which may be particularly relevant where scar format ion is associated with pathologic loss of life sustaining organ function.